Adelphi Values

What Adelphi Values does

Adelphi Values is a global healthcare value consultancy that operates two integrated practice areas—Patient-Centered Outcomes (PCO) and PROVE (Payer, Reimbursement, Outcomes, Value, Evidence)—serving pharmaceutical, biotech, medical device, and vaccine developers. The PCO practice advises on the selection, development, evaluation, and regulatory submission of Clinical Outcome Assessments (COAs) including Patient-Reported, Clinician-Reported, Observer-Reported, and Performance Outcomes. The PROVE practice delivers market access, health economics, value communication, and payer/reimbursement consulting across the product lifecycle.

The company operates a portfolio of proprietary methodologies and digital platforms, including Safety Profile Model™, Enhance™, PRISM™, SPACE™, PACE™, @-Delphi SENSUS™, REAL™, and the e-v@luate EVIDENCE™ and e-v@luate IMPACT™ digital tools. Service modules span literature and COA instrument reviews, qualitative patient-centered research, COA development/modification, patient preference research, psychometric and statistical analysis (using SAS, R, MPlus), COA regulatory submissions for FDA and EMA, scientific dissemination, value insight and communication, health economics and data analysis, and payer/reimbursement support. The company maintains a network of patient recruitment partners in over 30 countries.

Adelphi Values generates revenue through project-based professional services engagements with enterprise pharmaceutical and healthcare clients, with a B2B go-to-motion relying on direct senior-level relationships, scientific publications, industry conferences, and referrals through its parent Omnicom Health Group ecosystem (over 4,200 health specialists). The firm is a brand and operating division of Adelphi Group Ltd (UK), which became part of Omnicom Corporation in 1998 under Omnicom Health Group. With a team of 225+ experts, offices in London, Bollington, and Boston, and a track record of COA work tied to label claims for drugs such as Rinvoq, Humira, Dupixent, NUCALA, Cosentyx, Botox, and Xywav, the consultancy operates as a specialized mid-size niche player within the global HEOR/market access services market.

Name

Adelphi Values

Legal name

Adelphi Group Ltd

Website

https://adelphivalues.com

Company type

Private

Founded year

1993

Operating status

Operating

Headcount range

101–250 employees

Short description

Adelphi Values is a global healthcare value consultancy with 225+ experts, providing patient-centered outcomes research, health economics, market access, and COA regulatory support to pharmaceutical, biotech, medical device, and vaccine developers across the UK, US, and 30+ countries.

Ownership category

akta.pro rank

Product category

Healthcare Value Consulting

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Value Dossier & Evidence Generation (AMCP/Global Value Dossier) (HLAIAKAC)

akta.pro secondary industry

Clinical Quality Assurance (GCP QA, TMF/QMS oversight) (HLAGAKAI)

Keywords

• Health economics outcomes research
• Patient-reported outcomes research
• Market access consulting
• Clinical outcome assessments
• Pharmaceutical value consulting

Headquarters

HQ city

Boston

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Professional Consulting Services: Healthcare value consultancy providing strategic consulting services throughout product development and commercialization. Services include patient-centered outcomes research, health economics, market access support, and regulatory submissions. Revenue generated through project-based consulting engagements with pharmaceutical and healthcare clients.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Adelphi Values is a global healthcare value consultancy providing strategic consulting services to pharmaceutical, biotech, medical device, and vaccine developers. The company operates two integrated practice areas: Patient-Centered Outcomes (PCO), which advises on the selection, development, evaluation, and regulatory submission of Clinical Outcome Assessments (COAs), and PROVE, which delivers market access, health economics, payer engagement, and value communication services throughout the product lifecycle. The firm supports clients from pipeline prioritization and study design through regulatory approval, reimbursement, and commercialization.

Product overview

Adelphi Values is a global healthcare value consultancy offering two integrated practice areas: Patient-Centered Outcomes (PCO) and PROVE (market access and HEOR support). The PCO practice provides services for Clinical Outcome Assessment (COA) development including literature and instrument reviews, qualitative research, instrument development/modification, patient preference research, psychometric evaluation, regulatory submissions, and scientific dissemination. The PROVE practice encompasses Value Insight & Communication, Health Economics & Data Analysis, and Payer & Reimbursement services. The company also offers proprietary digital tools and methodologies including e-v@luate EVIDENCE™ and e-v@luate IMPACT™ digital platforms, Safety Profile Model™, Enhance™, PRISM™, SPACE™, PACE™, and @-Delphi SENSUS™ models and methodologies. Together, these services help pharmaceutical and medical product companies demonstrate healthcare value throughout product development and commercialization.

Differentiator

Problem solved

Functional benefit

Products and services

• PCO (Patient-Centered Outcomes) A specialized consulting practice that advises pharmaceutical and medical product developers on the selection, development, evaluation, and implementation of Clinical Outcome Assessments (COAs), including Patient-Reported Outcomes (PROs), Clinician-Reported Outcomes (ClinROs), Observer-Reported Outcomes (ObsROs), and Performance Outcomes (PerfOs), to facilitate regulatory approval and market access.
• PROVE (Payer, Reimbursement, Outcomes, Value, Evidence) A market access and HEOR consulting practice providing value insight and communication, health economics and data analysis, and payer and reimbursement services throughout the product lifecycle to help clients navigate the complex reimbursement and access landscape.
• Safety Profile Model A proprietary modelling framework that utilizes safety data to demonstrate wider patient and payer benefits, used within Adelphi Values' health economics engagements.
• Enhance A proprietary approach to the design, conduct, and analysis of trial experience interviews to enhance understanding of patient experiences and perspectives.
• PRISM (Policy and Return on Investment Scenario Model) A scenario-based model to facilitate evidence-based discussions with policy makers on investment in prevention of ill health.
• SPACE (Strategic Planning and Communication of Evidence) A methodology to proactively plan the generation of value evidence in a strategic manner with cross-functional teams, bridging clinical, medical, commercial, HEOR, and access functions.
• e-v@luate EVIDENCE A digital platform to consolidate, organize, and navigate all value-based evidence for healthcare products.
• e-v@luate IMPACT A digital tool to visualize and communicate health economic information.
• PACE (Policy, Affordability and Cost-Effectiveness model) A multi-comparator cost-effectiveness analysis model that provides results required to inform wider policy and implementation decisions.
• @-Delphi SENSUS A comprehensive, mixed-method approach using Delphi methodologies to address evidence gaps and garner expert consensus among stakeholders.

Quantifiable outcome

• Multiple FDA and EMA regulatory approvals for COA label claims across major pharmaceutical products including Rinvoq, NUCALA, Dupixent, and others
• +1 more outcomes

Named customers11 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature9 records

Partnerships

Five partnerships are on record, tiered core and flagship.

• Adelphi GroupcoreOthersParent company of Adelphi Values. Founded originally in 1986, provides overarching organizational structure and resources. Adelphi Group became part of Omnicom Corporation in 1998.
• Omnicom Health GroupcoreStrategic or Co-development PartnerDivision of Omnicom Corporation dedicated to health. Provides access to expertise, insight, creativity and scale to engage customers across the entire healthcare ecosystem. Adelphi Values benefits from this network of over 4,200 health specialists.
• Critical Path InstituteflagshipStrategic or Co-development PartnerCollaborated with Critical Path Institute and consortium of pharmaceutical sponsors to lead development and validation of Asthma Daytime Symptom Diary (ADSD) and Asthma Nighttime Symptom Diary (ANSD). These measures are among the first COAs to be qualified by FDA as part of Drug Development Tool Qualification Program.
• Patient Advocacy GroupscoreStrategic or Co-development PartnerRegularly partner with patient advocacy groups and charitable bodies to access specific or hard to reach disease populations for qualitative research studies.
• Patient Recruitment Partners (30+ countries)coreChannel Partner/ Reseller/ DistributorExtensive network of trusted patient recruitment partners in over 30 countries. Partners assist with recruitment, moderation and transcription/translation activities for qualitative studies.

Scale indicators5 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• Evidera (PPD/Thermo Fisher Scientific): One of the largest dedicated HEOR, market access, and patient-centered outcomes consultancies, serving similar pharma/biotech clients with overlapping value evidence and PRO services.
• RTI Health Solutions: Nonprofit-affiliated health economics and patient-centered outcomes consultancy with a comparable footprint in PRO/COA, HEOR, and market access research.
• Putnam Associates: Strategy consulting firm focused on pharmaceutical and biotech clients across market access, pricing, and commercial strategy — closely comparable on payer/value engagements.
• Xcenda (Cencora/AmerisourceBergen): Specialized HEOR, market access, and payer consulting firm within Cencora, directly comparable in service mix to Adelphi Values' PROVE practice.
• Creativ-Ceutical: European-based HEOR, market access, and patient-centered outcomes consultancy competing in similar value evidence and HTA support work.
• Open Health Group (now part of Fishawack): Multi-disciplinary healthcare consultancy with HEOR, market access, and patient engagement practices; comparable in services and client base to Adelphi Values.
• BresMed Health Solutions: Specialist health economics and market access consultancy providing HEOR, modeling, and value communication services to pharma clients — a focused competitor in the same niche.

Broad incumbents

• Parexel (HEOR/Market Access practice): Global CRO with a dedicated HEOR and market access consulting practice serving similar pharma clients on value evidence generation and reimbursement strategy.
• IQVIA (Real World Evidence / HEOR practice): Global CRO/technology incumbent with extensive HEOR, real-world evidence, and patient-centered research capabilities, competing across all Adelphi Values service lines as part of a broader portfolio.
• ICON plc (formerly PRA Health Sciences, HEOR): Large CRO offering market access, HEOR, and patient-centered outcomes services, competing with Adelphi Values on multi-asset pharma engagements.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/adelphivalues
• Facebookfacebook.com/adelphi-values-577025302318958
• LinkedInlinkedin.com/company/adelphi-values

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Adelphi Values